New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Longeveron Inc.
LGVN
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

31M

Biotechnology

Next Earning date - 08 Nov 2024

31M

Biotechnology

Next Earning date - 08 Nov 2024

2.18USD
Shape-0.00 ( -0.03%)
Market Open
favorite-chart

Relative Strenght

0
favorite-chart

Volume Buzz

-3%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

91%

Quote Panel

Shape
Updated October 29, 2024
1W -1.71 % 1M 12.47 % 3M -33.27 % 1Y -88.69 %

Key Metrics

Shape
  • Market Cap

    31.29M


  • Shares Outstanding

    14.36M


  • Share in Float

    13.48M


  • Dividende

    0


  • Earning Date

    08 Nov 2024


  • Price Target

    2.1793


  • Average Volume

    733226


  • Beta

    0.351


  • Range

    0.771-23.9


  • Industry

    Biotechnology


  • Website

    https://www.longeveron.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

25.59x

P/S Ratio

0.96x

P/B Ratio

0.1

Debt/Equity

-1578.8%

Net Margin

$-8.9

EPS

How LGVN compares to sector?

P/E Ratio

Relative Strength

Shape

LGVN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$2M

Shape322%

2025-Revenue

$1.53

Shape-195%

2025-EPS

$2M

Shape53%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.25
vs -0.25

Q4.22

arrow
arrow

N/A

-0.21
vs -0.20

Q1.23

arrow
arrow

N/A

-0.22
vs -0.17

Q2.23

arrow
arrow

N/A

-0.27
vs -0.27

Q3.23

arrow
arrow

N/A

-0.28
vs -0.25

Q4.23

arrow
arrow

N/A

-2.50
vs -0.21

Q1.24

arrow
arrow

N/A

-1.61
vs -0.22

Q2.24

arrow
arrow

N/A

-1.83
vs -0.27

Q3.24

arrow
arrow

N/A

-0.39
vs -0.28

Q4.24

arrow
arrow

N/A

-0.35
vs -2.50

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+14%

265K  vs 232K

Q4.22

arrow
arrow

-42%

121K  vs 209K

Q1.23

arrow
arrow

-25%

279K  vs 370K

Q2.23

arrow
arrow

-53%

217K  vs 466K

Q3.23

arrow
arrow

-43%

150K  vs 265K

Q4.23

arrow
arrow

-48%

63K  vs 121K

Q1.24

arrow
arrow

+96%

548K  vs 279K

Q2.24

arrow
arrow

+116%

468K  vs 217K

Q3.24

arrow
arrow

+164%

395.5K  vs 150K

Q4.24

arrow
arrow

+548%

408K  vs 63K

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-22%

-0.22
vs -0.24

Q4.22

arrow
arrow

-18%

-0.18
vs -0.22

Q1.23

arrow
arrow

-28%

-0.28
vs -0.18

Q2.23

arrow
arrow

-50%

-0.50
vs -0.28

Q3.23

arrow
arrow

-89%

-0.89
vs -0.50

Q4.23

arrow
arrow

-88%

-0.88
vs -0.89

Q1.24

arrow
arrow

-133%

-1.33
vs -0.88

Q2.24

arrow
arrow

-23%

-0.23
vs -1.33

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

14

14
vs 13

8%

Q4.22

arrow
arrow

16

16
vs 14

14%

Q1.23

arrow
arrow

14

14
vs 16

-12%

Q2.23

arrow
arrow

20

20
vs 14

43%

Q3.23

arrow
arrow

18

18
vs 20

-10%

Q4.23

arrow
arrow

20

20
vs 18

11%

Q1.24

arrow
arrow

11

11
vs 20

-45%

Q2.24

arrow
arrow

18

18
vs 11

64%

Earnings Growth

Latest News